|
1
|
Chandrasekharappa SC, Guru SC, Manickam P,
Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z,
Lubensky IA, Liotta LA, et al: Positional cloning of the gene for
multiple endocrine neoplasia-type 1. Science. 276:404–407. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lemmens I, Van de Ven WJ, Kas K, Zhang CX,
Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G, et
al: Identification of the multiple endocrine neoplasia type 1
(MEN1) gene. The European Consortium on MEN1. Hum Mol Genet.
6:1177–1183. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pannett AA and Thakker RV: Somatic
mutations in MEN type 1 tumors, consistent with the Knudson
'two-hit' hypothesis. J Clin Endocrinol Metab. 86:4371–4374.
2001.PubMed/NCBI
|
|
4
|
Carling T: Multiple endocrine neoplasia
syndrome: Genetic basis for clinical management. Curr Opin Oncol.
17:7–12. 2005. View Article : Google Scholar
|
|
5
|
Leotlela PD, Jauch A, Holtgreve-Grez H and
Thakker RV: Genetics of neuroendocrine and carcinoid tumours.
Endocr Relat Cancer. 10:437–450. 2003. View Article : Google Scholar
|
|
6
|
Brandi ML, Gagel RF, Angeli A, Bilezikian
JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG,
Libroia A, et al: Guidelines for diagnosis and therapy of MEN type
1 and type 2. J Clin Endocrinol Metab. 86:5658–5671. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lemos MC and Thakker RV: Multiple
endocrine neoplasia type 1 (MEN1): Analysis of 1336 mutations
reported in the first decade following identification of the gene.
Hum Mutat. 29:22–32. 2008. View Article : Google Scholar
|
|
8
|
Eckel F and Jelic S; ESMO Guidelines
Working Group: Billiary cancer: ESMO clinical recommendation for
diagnosis, treatment and follow-up. Ann Oncol. 20(Suppl 4): 46–48.
2009. View Article : Google Scholar
|
|
9
|
Mailman MD, Muscarella P, Schirmer WJ,
Ellison EC, O'Dorisio TM and Prior TW: Identification of MEN1
mutations in sporadic enteropancreatic neuroendocrine tumors by
analysis of paraffin-embedded tissue. Clin Chem. 45:29–34.
1999.PubMed/NCBI
|
|
10
|
Nagamura Y, Yamazaki M, Shimazu S, Sano K,
Tsukada T and Sakurai A: A novel splice site mutation of the MEN1
gene identified in a patient with primary hyperparathyroidism.
Endocr J. 59:523–530. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hai N, Aoki N, Shimatsu A¸ Mori T and
Kosugi S: Clinical features of multiple endocrine neoplasia type 1
(MEN1) phenocopy without germline MEN1 gene mutations: Analysis of
20 Japanese sporadic cases with MEN1. Clin Endocrinol (Oxf).
52:509–518. 2000. View Article : Google Scholar
|
|
12
|
Raghavan R, Shah S, Kondkar AA, Dherai AJ,
Desai D, Chauhan P, Lala M and Ashavaid TF: MEN1 935-1G>C
splicing mutation in an Indian patient with multiple endocrine
neoplasia type 1. Mol Diagn Ther. 11:129–131. 2007. View Article : Google Scholar
|
|
13
|
Modlin IM, Moss SF, Chung DC, Jensen RT
and Snyderwine E: Priorities for improving the management of
gastroen-teropancreatic neuroendocrine tumors. J Natl Cancer Inst.
100:1282–1289. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Machens A, Schaaf L, Karges W, Frank-Raue
K, Bartsch DK, Rothmund M, Schneyer U, Goretzki P, Raue F and
Dralle H: Age related penetrance of endocrine tumours in multiple
endocrine neoplasia type 1 (MEN1): A multicentre study of 258 gene
carriers. Clin Endocrinol (Oxf). 67:613–622. 2007.
|
|
15
|
Ehehalt F, Saeger HD, Schmidt CM and
Grützmann R: Neuroendocrine tumors of the pancreas. Oncologist.
14:456–467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thakker RV, Newey PJ, Walls GV, Bilezikian
J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML,
et al: Clinical practice guidelines for multiple endocrine
neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 97:2990–3011.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Imamura M, Komoto I, Ota S, Hiratsuka T,
Kosugi S, Doi R, Awane M and Inoue N: Biochemically curative
surgery for gastrinoma in multiple endocrine neoplasia type 1
patients. World J Gastroenterol. 17:1343–1353. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schreinemakers JM, Pieterman CR, Scholten
A, Vriens MR, Valk GD and Rinkes IH: The optimal surgical treatment
for primary hyperparathyroidism in MEN1 patients: A systematic
review. World J Surg. 35:1993–2005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lopez CL, Falconi M, Waldmann J,
Boninsegna L, Fendrich V, Goretzki PK, Langer P, Kann PH, Partelli
S and Bartsch DK: Partial pancreaticoduodenectomy can provide cure
for duodenal gastrinoma associated with multiple endocrine
neoplasia type 1. Ann Surg. 257:308–314. 2013. View Article : Google Scholar
|
